Latest News about RHHBY
Recent news which mentions RHHBY
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Kiniksa Inks Global License Agreement With Roche For Vixarelimab
August 03, 2022
From Benzinga
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Motley Fool
From Benzinga
Why Shares of Agenus Inc. Rose 10.1% on Tuesday
July 26, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
From Benzinga
From Benzinga
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
July 18, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
10 Most Traded OTC Stocks In June: Where Do Danone, Adidas And Grayscale Bitcoin Trust Rank?
July 06, 2022
From Benzinga
From Benzinga
From Benzinga
The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May
June 17, 2022
From Benzinga
Why Mereo BioPharma Shares Are Jumping Today
June 17, 2022
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
ASCO 2022: Surprising News in Cancer Research
June 10, 2022
From Motley Fool
5 Cash-Cow Stocks to Buy for a Turbulent Market
June 10, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.